vimarsana.com

Page 2 - நிறுவனம் க்கு உயிர் பொறியியல் ஆஃப் கட்டலோனியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Environmental News Network - DAM and IBEC Develop a Drone That Improves Odor Management in Water Treatment Plants

Environmental News Network - DAM and IBEC Develop a Drone That Improves Odor Management in Water Treatment Plants
enn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from enn.com Daily Mail and Mail on Sunday newspapers.

A new 3D model for myotonic dystrophy

A new 3D model for myotonic dystrophy Myotonic dystrophy is a hereditary degenerative neuromuscular disease that occurs mainly in adults, affecting about 50,000 people only in Spain. Symptoms range from difficulty walking and myotonia (great difficulty in relaxing the contracted muscles) to severe neurological problems, leading to progressive disability that unfortunately puts many of those affected in a wheelchair. This disease is very heterogeneous among patients (age of onset, progression, hereditary transmission, affected muscles), which makes the development of generic treatments especially complex. Currently, drugs against myotonic dystrophy are developed in animal models such as Drosophila, the fruit fly, or in 2D cell cultures. They are later tested in mice and finally in patients. Unfortunately using these approaches, some of the drugs that have been developed have not been able to reach the last stages of clinical trials because they were not effective in patients, hig

Artidis AG: ARTIDIS enters clinical collaboration to investigate nanomechanical profiling as a novel diagnostic and treatment optimization approach in patients with lung cancer

Artidis AG: ARTIDIS enters clinical collaboration to investigate nanomechanical profiling as a novel diagnostic and treatment optimization approach in patients with lung cancer the ation in the ARTIDISNet platform . In this research collaboration, ARTIDIS and teams from the University of Barcelona and Hospital Clínic de Barcelona will perform comparative analyses of nanomechanical profiles of cancer tissue and sub-cellular components, i.e. tumor microenvironments (TME), in human lung biopsies of patients with NSCLC undergoing surgery at the Hospital Clinic of Barcelona. The teams will use the proprietary ARTIDIS technology that provides nanomechanical profiling, based on atomic force microscopy of patient-derived tissues directly at the patient s bedside, and combines it with extensive clinical information to deliver fast diagnosis and optimized treatment plans. This 18-month study aims at identifying distinct nanomechanical signatures of major histological subtypes of NSCLC

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.